OR WAIT null SECS
July 27, 2023
The partnership is an extension of the collaboration from AbbVie and Scripps Research that was formed in 2019, according to the press release.
July 25, 2023
The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.
July 24, 2023
Sanofi and Recludix Pharma’s deal centers on developing treatments for various immunological and inflammatory diseases.
Newly launched Crossbow Therapeutics will work to advance a novel class of antibody therapies for treating cancers.
July 21, 2023
Under a global license agreement, Bristol Myers Squibb and Evotec will advance the development of neurodegeneration pipeline assets.
The proposed spin-off of Sandoz into an independent entity has been approved by Novartis’ board of directors.
The partnership will see Flagship and Pfizer work to create a new pipeline of innovative medicines.
The expanded deal, now potentially worth more than $1.2 billion, will work to develop in vivo therapies, including sickle cell disease.
July 20, 2023
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.
The new drug may help vulnerable children resist RSV in the coming fall and winter season.